Prenatal whole-genome sequencing - Is the quest to know a fetus's future ethical?

New England Journal of Medicine

Volumn 370, Issue 3, 2014, Pages 195-197

  Yurkiewicz, Ilana R ^a   Korf, Bruce R ^c   Lehmann, Lisa Soleymani ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; ACCESS TO INFORMATION; AMNIOCENTESIS; CHORION VILLUS SAMPLING; GENE SEQUENCE; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; HUMAN; INFERTILITY THERAPY; MEDICAL DECISION MAKING; MEDICAL ETHICS; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SHORT SURVEY; WHOLE GENOME SEQUENCING; WOMEN'S RIGHTS;

EID: 84892585067     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1215536     Document Type: Article

References (5)

1. Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR. Non-invasive prenatal measurement of the fetal genome. Nature 2012;487:320-4. [Erratum, Nature 2012;489:326.]
2. Newborn screening: toward a uniform screening panel and system. Bethesda, MD: American College of Medical Genetics, 2005.
3. The changing moral focus of newborn screening: an ethical analysis by the President's Council on Bioethics. Washington, DC: President's Council on Bioethics, 2008.
4. Ross LF, Saal HM, David KL, Anderson RR. Ethical and policy issues in genetic testing and screening of children. Genet Med 2013;15:234-45. [Erratum, Genet Med 2013; 15:321.]
5. Green RC, Roberts JS, Cupples LA, et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009;361:245-54.